These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24524135)

  • 1. CRISPRs and epigenome editing.
    Rusk N
    Nat Methods; 2014 Jan; 11(1):28. PubMed ID: 24524135
    [No Abstract]   [Full Text] [Related]  

  • 2. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
    Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
    Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining CRISPR-based genome and epigenome editing off-targets.
    Luo Y
    Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
    [No Abstract]   [Full Text] [Related]  

  • 4. CRISPR: gene editing is just the beginning.
    Ledford H
    Nature; 2016 Mar; 531(7593):156-9. PubMed ID: 26961639
    [No Abstract]   [Full Text] [Related]  

  • 5. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 6. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
    Maier LK; Marchfelder A; Randau L
    Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
    [No Abstract]   [Full Text] [Related]  

  • 7. And Then There Were Three: Discovering the Role of CRISPRs.
    Vergnaud G
    CRISPR J; 2019 Dec; 2(6):359-361. PubMed ID: 31860354
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercompact CRISPR-Cas12j2 (CasĪ¦) enables genome editing, gene activation, and epigenome editing in plants.
    Liu S; Sretenovic S; Fan T; Cheng Y; Li G; Qi A; Tang X; Xu Y; Guo W; Zhong Z; He Y; Liang Y; Han Q; Zheng X; Gu X; Qi Y; Zhang Y
    Plant Commun; 2022 Nov; 3(6):100453. PubMed ID: 36127876
    [No Abstract]   [Full Text] [Related]  

  • 9. CRISPR/dCas-mediated transcriptional and epigenetic regulation in plants.
    Pan C; Sretenovic S; Qi Y
    Curr Opin Plant Biol; 2021 Apr; 60():101980. PubMed ID: 33401227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
    Pei WD; Zhang Y; Yin TL; Yu Y
    Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
    Duroux-Richard I; Giovannangeli C; Apparailly F
    Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing for plant research and crop improvement.
    Zhan X; Lu Y; Zhu JK; Botella JR
    J Integr Plant Biol; 2021 Jan; 63(1):3-33. PubMed ID: 33369120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X; Qi LS
    J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational designs of in vivo CRISPR-Cas delivery systems.
    Xu CF; Chen GJ; Luo YL; Zhang Y; Zhao G; Lu ZD; Czarna A; Gu Z; Wang J
    Adv Drug Deliv Rev; 2021 Jan; 168():3-29. PubMed ID: 31759123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying gene-editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer's disease.
    Schrauben M; Dempster E; Lunnon K
    Brain Pathol; 2020 Sep; 30(5):992-1004. PubMed ID: 32654206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome and epigenome engineering CRISPR toolkit for
    Williams RM; Senanayake U; Artibani M; Taylor G; Wells D; Ahmed AA; Sauka-Spengler T
    Development; 2018 Feb; 145(4):. PubMed ID: 29386245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges.
    Cheng X; Fan S; Wen C; Du X
    Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve genes at one blow: multiplex genome editing with CRISPR/Cas.
    Verhage L
    Plant J; 2021 Apr; 106(1):6-7. PubMed ID: 33861513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.